Phase 1, Phase 2 and Phase 3 Clinical Trials

Phase 1, Phase 2 and Phase 3 Studies

Phase I/Ib Clinical Studies
Phase I and Ib studies are conducted in close collaboration with ICON International. ICON and UMCG have a joined  Clinical Research Unit (CRU) on the premises of the UMCG. ICON and the department of Cardiology have extensive experience in conducting fast track phase 1 safety and tolerability studies, with the addition of small groups of patients for early efficacy evaluation.

Phase IIa/IIb Clinical Studies
Cardio Research, the dedicated research unit of the department of Cardiology, has over 15 years of experience in conducting Phase 2a/b studies. In collaboration with the UMCG we can offer a wide array of (invasive) techniques to add sophisticated scientific data to your drug profile. Also overnight confinement of patients is a service we can offer.

Phase III Clinical Studies
Cardio Research, the dedicated research unit of the department of Cardiology, has over 25 years of experience in conducting Phase 3 studies.